- http://dx. doi. org/10.1016/j. brs. 2017.01. 579 1935-861X/© 2017 Elsevier Inc. All rights reserved. dTMS over the dmPFC-ACC shows potential benefit in TRD patients who failed lateral PFC stimulation treatments and should be further studied as a potential treatment for TRD patients. Further structured investigations should attempt to identify a priori biomarkers for the type of treatment most relevant for the individual.